Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001667:Binding, Competitive; D001933:Brain Stem / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D002729:Chloromercuribenzoates / Q000494:pharmacology; D003061:Codeine / Q000494:pharmacology; D003915:Dextromethorphan / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005260:Female; D003932:Heroin / Q000494:pharmacology; D066298:In Vitro Techniques; D007981:Levorphanol / Q000494:pharmacology; D008691:Methadone / Q000494:pharmacology; D009019:Morphinans / Q000037:antagonists & inhibitors*; D009020:Morphine / Q000037:antagonists & inhibitors; D009269:Nalorphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D013329:Structure-Activity Relationship; D013347:Subcellular Fractions; D013570:Synaptic Membranes / Q000187:drug effects*; D014316:Tritium
D002729:Chloromercuribenzoates; D009019:Morphinans; D011955:Receptors, Drug; D014316:Tritium; D007981:Levorphanol; D009270:Naloxone; D003932:Heroin; D003915:Dextromethorphan; D009020:Morphine; D010830:Physostigmine; D000109:Acetylcholine; D005033:Ethylmaleimide; D009269:Nalorphine; D008691:Methadone; D003061:Codeine